Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$26.64 - $40.31 $4 Million - $6.05 Million
-150,000 Reduced 48.41%
159,846 $5.63 Million
Q2 2023

Aug 14, 2023

SELL
$34.33 - $62.11 $9.88 Million - $17.9 Million
-287,877 Reduced 48.16%
309,846 $17.8 Million
Q3 2022

Nov 14, 2022

SELL
$22.23 - $33.37 $9.18 Million - $13.8 Million
-413,046 Reduced 40.86%
597,723 $16.9 Million
Q2 2022

Aug 15, 2022

SELL
$19.74 - $43.01 $3.74 Million - $8.14 Million
-189,245 Reduced 15.77%
1,010,769 $21.9 Million
Q4 2021

Feb 14, 2022

SELL
$43.27 - $65.72 $5.02 Million - $7.62 Million
-115,938 Reduced 8.81%
1,200,014 $56.9 Million
Q3 2021

Nov 15, 2021

SELL
$53.61 - $67.5 $24.2 Million - $30.5 Million
-451,398 Reduced 25.54%
1,315,952 $74.5 Million
Q2 2021

Aug 16, 2021

SELL
$45.13 - $64.99 $22.8 Million - $32.8 Million
-505,128 Reduced 22.23%
1,767,350 $101 Million
Q1 2021

May 17, 2021

SELL
$29.77 - $84.85 $19.3 Million - $55.1 Million
-649,293 Reduced 22.22%
2,272,478 $144 Million
Q4 2020

Feb 16, 2021

SELL
$25.66 - $34.55 $1.44 Million - $1.94 Million
-56,061 Reduced 1.88%
2,921,771 $98 Million
Q3 2020

Nov 16, 2020

BUY
$22.51 - $30.11 $50,647 - $67,747
2,250 Added 0.08%
2,977,832 $81.4 Million
Q2 2020

Aug 17, 2020

BUY
$12.65 - $29.57 $75,900 - $177,420
6,000 Added 0.2%
2,975,582 $80.5 Million
Q2 2019

Aug 13, 2019

BUY
$18.0 - $19.82 $53.5 Million - $58.9 Million
2,969,582 New
2,969,582 $58.9 Million

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Omega Fund Management, LLC Portfolio

Follow Omega Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omega Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Omega Fund Management, LLC with notifications on news.